Terms: = Colorectal cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
1845 results:
1. Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic colorectal cancer.
Andre T; Elez E; Van Cutsem E; Jensen LH; Bennouna J; Mendez G; Schenker M; de la Fouchardiere C; Limon ML; Yoshino T; Li J; Lenz HJ; Manzano Mozo JL; Tortora G; Garcia-Carbonero R; Dahan L; Chalabi M; Joshi R; Goekkurt E; Braghiroli MI; Cil T; Cela E; Chen T; Lei M; Dixon M; Abdullaev S; Lonardi S;
N Engl J Med; 2024 Nov; 391(21):2014-2026. PubMed ID: 39602630
[TBL] [Abstract] [Full Text] [Related]
2. Associations Between Dietary Patterns and Quality of Life in a Longitudinal Cohort of colorectal cancer Survivors.
Smith KS; Gudenkauf LM; Hoogland AI; Li X; Hoobler R; Playdon MC; Gigic B; Small BJ; Gonzalez BD; Oswald LB; Byrd DA; Greathouse KL; Ulrich CM; Li CI; Shibata D; Toriola AT; Peoples AR; Siegel EM; Figueiredo JC; Jim HSL; Crowder SL
Nutrients; 2024 Nov; 16(22):. PubMed ID: 39599646
[TBL] [Abstract] [Full Text] [Related]
3. AMTAC-19, a Spiro-Acridine Compound, Induces In Vitro Antitumor Effect via the ROS-ERK/JNK Signaling Pathway.
Sousa VM; Duarte SS; Ferreira RC; Sousa NF; Scotti MT; Scotti L; Silva MSD; Tavares JF; Moura RO; Gonçalves JCR; Sobral MV
Molecules; 2024 Nov; 29(22):. PubMed ID: 39598733
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of risk factors for adverse outcomes in 10,135 patients with gastrointestinal malignancies aged 65 years and over who underwent elective surgery].
Wang W; Wang JP; Wang D; Cai HZ; Wu ZQ; Shan F; Li ZY
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Nov; 27(11):1155-1161. PubMed ID: 39572181
[No Abstract] [Full Text] [Related]
5. The impact of preoperative treatment on mismatch repair protein and HER2 expression in colorectal cancer: an analysis of paired samples.
Chen Z; Cao H; Zhang J; Zhong W; Teng X
BMC Cancer; 2024 Nov; 24(1):1407. PubMed ID: 39548392
[TBL] [Abstract] [Full Text] [Related]
6. Germline Variants in DNA Interstrand-Cross Link Repair Genes May Contribute to Increased Susceptibility for Serrated Polyposis Syndrome.
Silva P; Francisco I; Filipe B; Lage P; Rosa I; Fernandes S; Fonseca R; Rodrigues P; Parreira J; Claro I; Albuquerque C
Int J Mol Sci; 2024 Nov; 25(21):. PubMed ID: 39519399
[TBL] [Abstract] [Full Text] [Related]
7. SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study.
Zhang P; Li X; Wang X; Yang Y; Wang J; Cao D
Front Immunol; 2024; 15():1450533. PubMed ID: 39445023
[TBL] [Abstract] [Full Text] [Related]
8. LABORATORY PREDICTORS FOR DIAGNOSING colorectal ANASTOMOTIC LEAKAGE.
Gordiichuk M; Myasoyedov S
Exp Oncol; 2024 Oct; 46(2):146-153. PubMed ID: 39396169
[TBL] [Abstract] [Full Text] [Related]
9. Impact of the Early Phase of the COVID-19 Pandemic on the Quality of Care for colorectal and Anal cancers at Comprehensive cancer Centers on Two Continents.
Saldanha EF; Powis M; Sharma D; Espin-Garcia O; Hack S; Cavalher F; Costa MR; Simoes M; Li H; Baiad A; Chen K; Mohmand Z; Nakhla P; Aguiar S; Riechelmann R; Krzyzanowska MK
JCO Glob Oncol; 2024 Sep; 10():e2400037. PubMed ID: 39348613
[TBL] [Abstract] [Full Text] [Related]
10. Risk of Gastric and Small Intestinal cancer in Patients With Lynch Syndrome: Data From a Large, Community-Based US Population.
Lin CF; Carwana HE; Jiang SF; Li D
Clin Transl Gastroenterol; 2024 Sep; 15(9):e1. PubMed ID: 39320958
[TBL] [Abstract] [Full Text] [Related]
11. Erucic acid increases the potency of cisplatin-induced colorectal cancer cell death and oxidative stress by upregulating the TRPM2 channel.
Nazıroğlu A; Çarhan A; Nazıroğlu M
Cell Biol Int; 2024 Dec; 48(12):1862-1876. PubMed ID: 39308167
[TBL] [Abstract] [Full Text] [Related]
12. Complement is increased in treatment resistant rectal cancer and modulates radioresistance.
O'Brien RM; Meltzer S; Buckley CE; Heeran AB; Nugent TS; Donlon NE; Reynolds JV; Ree AH; Redalen KR; Hafeez A; O'Ríordáin DS; Hannon RA; Neary P; Kalbassi R; Mehigan BJ; McCormick PH; Dunne C; Kelly ME; Larkin JO; O'Sullivan J; Lysaght J; Lynam-Lennon N
Cancer Lett; 2024 Nov; 604():217253. PubMed ID: 39278399
[TBL] [Abstract] [Full Text] [Related]
13. MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal cancer.
Williams H; Omer DM; Thompson HM; Lin ST; Verheij FS; Miranda J; Yuval JB; Buckley J; Marco MR; Qin LX; Dombroski DA; Kedar R; Oto A; Korngold E; Veniero JC; Gandhi S; Krishnaraj A; Jagtiani M; Ohanian K; Vu D; Hope TA; Lee S; Wasnik AP; Madhuripan N; Gollub MJ; Garcia-Aguilar J;
Radiology; 2024 Sep; 312(3):e232748. PubMed ID: 39225603
[TBL] [Abstract] [Full Text] [Related]
14. Assessing risk factors for elevated creatine kinase levels as an indicator of compartment syndrome following laparoscopic or robot-assisted colorectal cancer surgery in the lithotomy-trendelenburg position.
Kusunoki C; Uemura M; Takeda M; Sekido Y; Hata T; Hamabe A; Ogino T; Miyoshi N; Kagawa Y; Tei M; Eguchi H; Doki Y
Surg Endosc; 2024 Oct; 38(10):6139-6145. PubMed ID: 39214881
[TBL] [Abstract] [Full Text] [Related]
15. Performance of Low-Dose Immunotherapy and Standard-Dose Immunotherapy in Microsatellite Instability-High Metastatic colorectal cancer: Real-World Data (CLouD-High Study).
Trikha M; Sarkar L; Dhanawat A; Syed N; Gujarathi H; Vora M; Sivakumar Raja AS; Bhargava P; Ramaswamy A; Mandavkar S; Saklani A; Kaushal RK; Bal M; Shetty O; Yadav S; Ostwal V
JCO Glob Oncol; 2024 Aug; 10():e2400141. PubMed ID: 39159410
[TBL] [Abstract] [Full Text] [Related]
16. Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study.
Cigliola A; Basnet A; Jacob JM; Mercinelli C; Tateo V; Patanè DA; Bratslavsky G; Cheng L; Grivas P; Kamat AM; Spiess PE; Pavlick DC; Lin DI; Ross JS; Necchi A
JCO Precis Oncol; 2024 Aug; 8():e2400200. PubMed ID: 39151108
[TBL] [Abstract] [Full Text] [Related]
17. A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801.
Nakatsumi H; Komatsu Y; Harada K; Kawamoto Y; Yuki S; Sawada K; Ishiguro A; Sogabe S; Ando T; Sasaki Y; Yoshikawa A; Nakamura M; Dazai M; Tateyama M; Muto O; Kotaka M; Sagawa T; Muranaka T; Hatanaka K; Takagi R; Sakata Y
Int J Cancer; 2024 Dec; 155(12):2223-2231. PubMed ID: 39143041
[TBL] [Abstract] [Full Text] [Related]
18. Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial.
Raghav K; Siena S; Takashima A; Kato T; Van den Eynde M; Pietrantonio F; Komatsu Y; Kawakami H; Peeters M; Andre T; Lonardi S; Yamaguchi K; Tie J; Castro CG; Hsu HC; Strickler JH; Kim TY; Cha Y; Barrios D; Yan Q; Kamio T; Kobayashi K; Boran A; Koga M; Allard JD; Yoshino T
Lancet Oncol; 2024 Sep; 25(9):1147-1162. PubMed ID: 39116902
[TBL] [Abstract] [Full Text] [Related]
19. Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial.
Xiao WW; Chen G; Gao YH; Lin JZ; Wu XJ; Luo HL; Lu ZH; Wang QX; Sun R; Cai PQ; Zhu CM; Liu M; Li JB; Wang YR; Jin Y; Wang F; Luo HT; Li CL; Pan ZZ; Xu RH
Cancer Cell; 2024 Sep; 42(9):1570-1581.e4. PubMed ID: 39094560
[TBL] [Abstract] [Full Text] [Related]
20. COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.
Segal NH; Tie J; Kopetz S; Ducreux M; Chen E; Dienstmann R; Hollebecque A; Reilley MJ; Elez E; Cosaert J; Cain J; Soo-Hoo Y; Hewson N; Cooper ZA; Kumar R; Tabernero J
Br J Cancer; 2024 Oct; 131(6):1005-1013. PubMed ID: 39048638
[TBL] [Abstract] [Full Text] [Related]
[Next]
